|
|
Volumn 362, Issue 9389, 2003, Pages 1078-1079
|
|
Confidentiality [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
CARCINOGENICITY;
CONSUMER;
DATA BASE;
DECISION MAKING;
DOCUMENTATION;
DRUG APPROVAL;
DRUG MANUFACTURE;
DRUG MARKETING;
EMBRYOTOXICITY;
HEALTH;
HUMAN;
INFORMATION;
INTERNET;
LETTER;
MUTAGENICITY;
ORGANIZATION;
PATIENT;
PHYSICIAN;
PRIORITY JOURNAL;
PRIVACY;
PROFESSIONAL SECRECY;
REGISTER;
TOXICITY;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFIDENTIALITY;
CONSUMER ADVOCACY;
DRUG INDUSTRY;
DRUG INFORMATION;
EUROPEAN MEDICINES EVALUATION AGENCY;
EUROPEAN UNION;
LEGAL ASPECT;
MEDICAL ETHICS;
ORGANIZATION AND MANAGEMENT;
STANDARD;
STATISTICS;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
EUROPEAN MEDICINES EVALUATION AGENCY;
CLINICAL PROTOCOLS;
CLINICAL TRIALS;
CODES OF ETHICS;
CONFIDENTIALITY;
CONSUMER ADVOCACY;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG INFORMATION SERVICES;
EUROPEAN UNION;
HUMANS;
|
|
EID: 0141537205
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)14424-8 Document Type: Letter |
|
Times cited : (3)
|
|
References (5)
|
